Comerica Bank
BLUE

Comerica Bank’s bluebird bio BLUE Stock Holding History

Comerica Bank’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-30
Closed -$835 – 3757
2023
Q4 		$835 Buy
+30
New +$1.83K ﹤0.01% 3636
2019
Q3 		– Sell
-148
Closed -$268K – 2276
2019
Q2 		$268K Sell
148
-2
-1% -$3.46K ﹤0.01% 2113
2019
Q1 		$305K Buy
150
+2
+1% +$3.52K ﹤0.01% 2052
2018
Q4 		$237K Sell
148
-8
-5% -$12.3K ﹤0.01% 2125
2018
Q3 		$240K Buy
156
+9
+6% +$18.6K ﹤0.01% 2128
2018
Q2 		$345K Buy
147
+14
+11% +$31.9K ﹤0.01% 2035
2018
Q1 		$295K Sell
133
-5
-4% -$12.7K ﹤0.01% 2074
2017
Q4 		$370K Buy
138
+6
+5% +$12.2K ﹤0.01% 2022
2017
Q3 		$242K Buy
+132
New +$184K ﹤0.01% 2120

Other funds holding BLUE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Comerica Bank's BLUE Position: Q1 2024 in Review

Comerica Bank sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 30 shares — an estimated $835 sold.

Comerica Bank first reported a position in BLUE in Q3 2017 and held it in 9 quarters. The position peaked at $370K in Q4 2017. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Comerica Bank reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Comerica Bank sold 30 bluebird bio shares in Q1 2024, an estimated $835.
  • Comerica Bank first reported a position in bluebird bio in Q3 2017 and held it in 9 quarters.
  • Comerica Bank's bluebird bio position peaked at $370K in Q4 2017.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Comerica Bank's 13F filing for Q1 2024, filed 16 May 2024.